Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_assertion type Assertion NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_head.
- NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_provenance.
- NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_assertion evidence source_evidence_literature NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_provenance.
- NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_assertion SIO_000772 14583448 NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_provenance.
- NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_assertion wasDerivedFrom befree-20140225 NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_provenance.
- NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_assertion wasGeneratedBy ECO_0000203 NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_provenance.